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During infection of the lung epithelium, Mycobacterium tuberculosis must infect and survive within macro-
phages long enough to be transported into deeper lung tissues. Cambier et al. (2013) show that pathogenic
mycobacteria use the coordinated action of two cell wall glycolipids to regulate macrophage recruitment to
initial infection sites.The cell wall of Mycobacterium tubercu-
losis and its close relative M. marinum
contains phthiocerol dimycocerosate
(PDIM) and the structurally related
phenolic glycolipids (PGL). However, the
functions of these lipids have remained
largely unclear, leading to much fascina-
tion and frustration over several decades.
Researchers reported in 1974 that clinical
M. tuberculosis isolates lacking PDIM
were attenuated in the guinea pig model
of infection, and 25 years later, two
groups independently presented genetic
proof for this association (Stanley and
Cox, 2013). Because spontaneous loss
ofM. tuberculosis PDIM occurs frequently
during in vitro passaging, many myco-
bacterial geneticists regard PDIM meta-
stability as an impetus for genetic
complementation of in vivo phenotypes.
The structurally related PGL also has a
perplexing history: laboratory strains and
many clinical isolates are naturally defi-
cient in PGL production (Reed et al.,
2004), and the contribution of the glyco-
lipid to M. tuberculosis virulence has
been controversial.
The roles of PDIM and PGL during infec-
tionhavealsoflummoxed thefieldbecause
of the inherent difficulties associated with
their analysis. Lipids, for example, are not
directly genetically encoded and therefore
are not amenable to traditional tagging
methods. Moreover, cell wall lipids may
have multiple, overlapping functions (Pas-
semar et al., 2013). As a consequence of
both technical and biological challenges,
the literature of mycobacterial lipids is
replete with controversy, and the mecha-
nismsbywhich thesemolecules contribute
to pathogenesis remain unclear.
Proposals for PDIM and PGL functions
are numerous but generally fall into threecategories (Passemar et al., 2013). First,
the glycolipids may have structural roles,
both within the bacterial envelope and
once inserted into host membranes. Sec-
ond, they may act as barriers to or repos-
itories for toxicmolecules. Third, theymay
directly interact with the immune system.
These hypotheses are not mutually exclu-
sive, and indeedCambier et al. (2013) now
demonstrate that mycobacterial glyco-
lipids play both structural and immuno-
modulatory roles during the earliest stage
of infection.
Cambier et al. (2013) began their study
by noting that Toll-like receptor (TLR)-
mediated immunity is important for pro-
tection against M. tuberculosis in vitro
but dispensable in both human and
animal studies. Given that the mycobac-
terial cell wall contains a plethora of
pathogen-associated molecular patterns
(PAMPs), any of which should theoreti-
cally induce TLR signaling, they hypothe-
sized that countermeasures that shield
these PAMPs from innate immune detec-
tion might also be present. To test this
idea, Cambier et al. (2013) employed the
M. marinum-zebrafish model of infection.
M. marinum is a close genetic relative of
M. tuberculosis and the causative agent
of ectotherm tuberculosis. By manipu-
lating both host and bacterium, Cambier
et al. (2013) demonstrated that PDIM
inhibits TLR signaling via the common
adaptor protein MyD88, which in turn
prevents the recruitment of microbicidal
macrophages to the earliest sites of
infection. They further demonstrate that
the permissive macrophages associated
with early wild-type M. marinum infection
are recruited via a host chemokine recep-
tor 2 (CCR2) pathway that is dependent
on the presence of PGL. Together, theseCell Host & Microbedata suggest that the PDIM and PGL gly-
colipids of virulent mycobacteria help
orchestrate the composition of the first
responding immune sentinels (Figure 1).
In contrast to the macrophages re-
cruited to the initial sites of wild-type
M. marinum infection, the majority of
macrophages recruited to PDIM-deficient
M.marinum expressed inducible nitric ox-
ide synthase (iNOS), an enzyme required
for production of microbicidal, reactive
nitrogen intermediates (RNS). Cambier
et al. (2013)were able to rescue thegrowth
of the mutant strain by the addition of
iNOS inhibitors, confirming that RNS
were responsible for bacterial attenuation
in the absence of PDIM. Although many
studies have found that M. tuberculosis
lacking PDIM are attenuated in vivo, they
have differed in their assessment of when
the defect occurs and what components
of host immunity are involved, particularly
the relative contributions of interferon
gamma (IFNg) cytokine signaling and
RNS (Kirksey et al., 2011; Murry et al.,
2009; Rousseau et al., 2004). Because
Cambier et al. (2013) were able to transfer
the MyD88, RNS-dependent attenuation
phenotype to PDIM-positive bacteria by
infecting in the presence of PDIM-nega-
tive bacteria, their experiments support a
model in which pathogenic mycobacteria
use the glycolipid to evade TLR detection
and subsequent RNS produced by micro-
bicidalmacrophages at the earliest stages
of infection. Notably, these data do not
rule out additional roles for the mycobac-
terial glycolipids in vivo, particularly within
macrophages or during later stages of
infection (Stanley and Cox, 2013).
Because they were able to attenuate
wild-type M. marinum infection by coin-
jecting crushed M. marinum, Cambier15, January 15, 2014 ª2014 Elsevier Inc. 1
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Figure 1. Mycobacterial Cell Wall Lipids Modulate Macrophage Composition at the Earliest
Sites of Infection
PDIM suppresses the recruitment ofmicrobicidal, iNOS-positivemacrophages by inhibiting TLR signaling,
while PGL stimulates the recruitment of more permissive, iNOS-negative macrophages via the CCR2
pathway.
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Previewset al. (2013) concluded that PDIM likely
functions in immune evasion by physically
masking cell wall PAMPs. Their findings
emphasize the importance of investi-
gating innate immune signaling in the
context of an intact pathogen and with
the full repertoire of immune cells present
in an intact host. However, many ques-
tions remain regarding the molecular
mechanisms by which the glycolipids
function. For example, does PDIM directly
block host access to underlying PAMPs,
or does it prevent release of the mole-
cules? What are the host components
that bind PGL in the CCR2 pathway or
PAMPs in PDIM-deficient strains? And
finally, when and where are glycolipids
and cell wall PAMPs presented to the
host immune system? Answering these
questions may require the development
of new tools with which to probe cell
wall components in vivo.
The interactions between the host
milieu and bacterial cell wall are likely to
be bidirectional and to change over the
course of infection. For example, in vivo
PDIM abundancemay depend on expres-
sion of the biosynthetic enzymes, which
decreases upon extended macrophage
infection (Rohde et al., 2012), shifts in
metabolic flux, which occur during host2 Cell Host & Microbe 15, January 15, 2014 ªlipid catabolism (Jain et al., 2007), and
insertion of the molecule into host mem-
branes (Astarie-Dequeker et al., 2009).
Thus, there may be variable amounts of
PDIM on the mycobacterial cell surface
at different time points after infection.
One corollary of this hypothesis is that
there may also be differential exposure
of M. tuberculosis PAMPs, which in turn
could shape the evolving relationship
between host and pathogen over the
course of an infection.
M. tuberculosis preferentially initiates
human infection in thedistal lung, a surface
that is largely devoid of the commensal
and environmental microbes found in the
upper respiratory tract. It may be that the
TLR signaling stimulated by the PAMPs
from these organisms overrides PDIM-
and PGL-mediated immune evasion.
In support of this hypothesis, Cambier
et al. (2013) found that coinfection of
M. marinum with Staphylococcus aureus
or Pseudomonas aeruginosa, common
oropharyngeal colonizers of the human
lung, attenuated wild-type M. marinum in
a MyD88-dependent fashion. Thus, TLR
signaling by commensal flora may protect
againstM. tuberculosis infection and force
the bacterium to infect via the less acces-
sible lower respiratory tract.2014 Elsevier Inc.Finally, this study highlights the many
advantages of the M. marinum-zebrafish
infection model. First, Cambier et al.
(2013) were able to discriminate between
relative contributions of different immune
components at both the level of cell type
and chemokine signaling. The optical
transparency of the zebrafish embryo,
moreover, allowed real-time, quantitative
imaging of pathogenic mycobacteria in-
fecting an intact host at the single-cell
level. Although bulk population measure-
ments of colony-forming units (cfu) in
various organs have yielded important
insights into host-pathogen interactions,
they offer static portraits of bacterial
burden with limited insight into the
kinetics of infection. As demonstrated by
Cambier et al. (2013), single-cell tracking
of both zebrafish host and mycobacterial
pathogen can facilitate complex, dynamic
models of tuberculosis.REFERENCES
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